HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimo Volpe Selected Research

rat atrial natriuretic peptide

1/2007Role of a molecular variant of rat atrial natriuretic Peptide gene in vascular remodeling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Massimo Volpe Research Topics

Disease

126Hypertension (High Blood Pressure)
11/2022 - 03/2002
57Heart Failure
04/2022 - 04/2002
39Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 10/2002
36Stroke (Strokes)
11/2022 - 11/2002
25Myocardial Infarction
11/2021 - 04/2002
15Acute Coronary Syndrome
01/2022 - 10/2005
14Neoplasms (Cancer)
02/2022 - 01/2011
13Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 06/2006
11COVID-19
04/2022 - 01/2020
11Inflammation (Inflammations)
04/2022 - 04/2007
11Type 2 Diabetes Mellitus (MODY)
03/2022 - 04/2002
10Atrial Fibrillation
01/2022 - 10/2010
10Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2022 - 01/2010
9Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2021 - 04/2007
8Vascular Diseases (Vascular Disease)
10/2021 - 04/2004
7Chronic Renal Insufficiency
11/2022 - 12/2012
7Atherosclerosis
11/2021 - 11/2008
7Obesity
01/2019 - 04/2007
7Hyperglycemia
01/2017 - 02/2003
6Cardiomyopathies (Cardiomyopathy)
06/2020 - 09/2009
6Left Ventricular Dysfunction
10/2018 - 01/2005
6Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
06/2018 - 01/2006
6Essential Hypertension
06/2015 - 08/2006
5Dyslipidemias (Dyslipidemia)
10/2022 - 08/2005
5Thrombosis (Thrombus)
04/2022 - 05/2011
5Cardiac Sudden Death (Sudden Cardiac Arrest)
07/2021 - 04/2013
5Diabetes Mellitus
11/2020 - 03/2007
5Myocardial Ischemia (Ischemic Heart Diseases)
09/2018 - 03/2012
5Ischemic Stroke
12/2011 - 04/2004
4Hypercholesterolemia
03/2022 - 07/2015
4Hemorrhage
01/2022 - 07/2014
4Hyperuricemia
01/2022 - 01/2010
4Stable Angina
01/2019 - 05/2012
4Fibrosis (Cirrhosis)
01/2018 - 05/2005
4Hypertrophy
12/2017 - 12/2009
4Pathologic Constriction (Stenosis)
06/2016 - 07/2005
4Ventricular Tachycardia
06/2015 - 12/2013
3Pneumonia (Pneumonitis)
04/2022 - 11/2020
3Albuminuria
01/2022 - 09/2012
3Body Weight (Weight, Body)
08/2021 - 03/2007
3Heart Diseases (Heart Disease)
05/2021 - 12/2013
3Sudden Death
12/2020 - 04/2013
3Vascular Remodeling
12/2020 - 01/2007

Drug/Important Bio-Agent (IBA)

54Antihypertensive Agents (Antihypertensives)IBA
07/2022 - 07/2003
29Angiotensin Receptor AntagonistsIBA
05/2021 - 04/2002
29Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2021 - 04/2002
23Atrial Natriuretic Factor (ANF)IBA
12/2021 - 02/2004
22Natriuretic PeptidesIBA
03/2022 - 04/2004
19Pharmaceutical PreparationsIBA
04/2022 - 05/2003
15Glucose (Dextrose)FDA LinkGeneric
08/2021 - 09/2009
13DiureticsIBA
11/2022 - 04/2002
12Biomarkers (Surrogate Marker)IBA
04/2022 - 11/2010
12SaltsIBA
11/2021 - 03/2002
12Olmesartan Medoxomil (Votum)FDA Link
05/2021 - 01/2009
11Uric Acid (Urate)IBA
11/2022 - 01/2010
11Proteins (Proteins, Gene)FDA Link
01/2019 - 03/2007
10sacubitril and valsartan sodium hydrate drug combinationIBA
04/2022 - 01/2018
10olmesartanIBA
01/2019 - 01/2009
10Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2018 - 11/2007
8Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 03/2007
8Angiotensin IIIBA
06/2018 - 08/2003
7LipidsIBA
10/2022 - 06/2011
7pro-brain natriuretic peptide (1-76)IBA
04/2022 - 09/2009
7CreatinineIBA
01/2022 - 11/2007
7Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2020 - 06/2014
7Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
06/2020 - 01/2005
7Ramipril (Altace)FDA LinkGeneric
01/2019 - 11/2010
6LDL CholesterolIBA
11/2022 - 01/2012
6Amlodipine (Norvasc)FDA LinkGeneric
09/2017 - 05/2003
5ReninIBA
03/2022 - 04/2002
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2022 - 08/2005
5AnticoagulantsIBA
01/2022 - 01/2013
5AlbuminsIBA
01/2022 - 01/2010
5Uncoupling Protein 2IBA
10/2021 - 02/2013
5Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
05/2021 - 01/2005
5SodiumIBA
01/2021 - 05/2005
5Hydrochlorothiazide (Esidrix)FDA LinkGeneric
09/2017 - 01/2009
5PotassiumIBA
01/2017 - 10/2006
4TroponinIBA
04/2022 - 01/2012
4AngiotensinsIBA
03/2022 - 04/2002
4Messenger RNA (mRNA)IBA
01/2022 - 12/2009
4Triglycerides (Triacylglycerol)IBA
01/2022 - 01/2012
4Hormones (Hormone)IBA
01/2022 - 01/2006
4Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2020 - 03/2002
4AntioxidantsIBA
01/2019 - 02/2013
3Ethanol (Ethyl Alcohol)IBA
11/2022 - 01/2020
3AldosteroneIBA
03/2022 - 05/2005
3EnalaprilFDA LinkGeneric
03/2022 - 02/2009
3Neprilysin (Neutral Endopeptidase)IBA
03/2022 - 06/2013
3Angiotensin Receptors (Angiotensin II Receptor)IBA
03/2022 - 11/2004
3Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2022 - 10/2014
3Angiotensin II Type 1 Receptor BlockersIBA
06/2020 - 03/2011
3mahuang-tangIBA
06/2020 - 01/2018

Therapy/Procedure

66Therapeutics
01/2022 - 10/2002
9Secondary Prevention
03/2022 - 04/2002
9Drug Therapy (Chemotherapy)
03/2022 - 01/2005
7Percutaneous Coronary Intervention
01/2022 - 04/2016
7Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
01/2019 - 12/2013
4Stents
01/2022 - 04/2016
4Cardiac Resynchronization Therapy
07/2015 - 03/2007